HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Stepping Back From The Cliff Edge: UK Industry Welcomes Northern Ireland Brexit Extension

Executive Summary

Companies supplying into Northern Ireland now have more time to prepare for post-Brexit regulatory changes in areas like batch testing, imports and Falsified Medicines Directive requirements. UK industry association, PAGB, in a joint statement with five other pharmaceutical industry associations, including AESGP, describes it as a step in the right direction, but also warns that there is still much work to do.

You may also be interested in...



UK Consumer Health Industry ‘Relieved’ By Post-Brexit Deal

UK consumer health industry association PAGB says it is "relieved" a last minute post-Brexit deal has been struck, which will enable its members to continue to supply OTCs to the EU with limited disruption. 

Brexit To Bring Regulatory Duplication, Possible Disruptions For UK Cosmetics Interests

As the transition period following the UK’s withdrawal from the European Union draws to a close, cosmetics industry stakeholders are following final trade negotiations while readying themselves for new regulatory complexities.

No Deal Brexit Could Mean 'Considerable Obstacles' For German OTC Exports

The dangers of a hard Brexit, a welcome delay to the EU Medical Devices Regulation and the impact of the coronavirus on the German OTC market all feature in this exclusive HBW Insight catch up with Germany's self-medication industry association, the BAH. 

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

RS150692

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel